New Delhi: The Drug Controller General of India (DCGI), Rajeev Raghuvanshi, has directed state authorities to withdraw AstraZeneca’s Olaparib Tablets, 100mg and 150mg, due to potential adverse ...
Olaparib for treating BRCA mutation-positive HER2-negative advanced breast cancer after chemotherapy
The list price of olaparib is £2,317.50 per 56 pack of 150-mg tablets (excluding VAT, BNF online, accessed October 2024). The company has a confidential commercial access agreement with NHS England.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback